- Home
- CKX vs VOR Comparison
CKX vs VOR Comparison
Compare CKX & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CKX
- VOR
- Stock Information
- Founded
- CKX 1930
- VOR 2015
- Country
- CKX United States
- VOR United States
- Employees
- CKX N/A
- VOR N/A
- Industry
- CKX Oil & Gas Production
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- CKX Energy
- VOR Health Care
- Exchange
- CKX Nasdaq
- VOR Nasdaq
- Market Cap
- CKX 21.4M
- VOR 22.1M
- IPO Year
- CKX 1998
- VOR 2021
- Fundamental
- Price
- CKX $10.70
- VOR $0.23
- Analyst Decision
- CKX
- VOR Buy
- Analyst Count
- CKX 0
- VOR 6
- Target Price
- CKX N/A
- VOR $7.20
- AVG Volume (30 Days)
- CKX 1.0K
- VOR 5.5M
- Earning Date
- CKX 05-12-2025
- VOR 05-14-2025
- Dividend Yield
- CKX N/A
- VOR N/A
- EPS Growth
- CKX N/A
- VOR N/A
- EPS
- CKX 0.37
- VOR N/A
- Revenue
- CKX $1,727,459.00
- VOR N/A
- Revenue This Year
- CKX N/A
- VOR N/A
- Revenue Next Year
- CKX N/A
- VOR N/A
- P/E Ratio
- CKX $29.46
- VOR N/A
- Revenue Growth
- CKX 18.18
- VOR N/A
- 52 Week Low
- CKX $10.04
- VOR $0.13
- 52 Week High
- CKX $14.14
- VOR $1.80
- Technical
- Relative Strength Index (RSI)
- CKX 41.61
- VOR 34.54
- Support Level
- CKX $11.00
- VOR $0.17
- Resistance Level
- CKX $11.48
- VOR $0.20
- Average True Range (ATR)
- CKX 0.24
- VOR 0.03
- MACD
- CKX -0.03
- VOR 0.02
- Stochastic Oscillator
- CKX 15.97
- VOR 67.19
About CKX CKX Lands Inc.
CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. CKX has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Surface segment. Geographically, it generates all of its revenue from the United States of America.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.